Major depression with mood‐congruent psychotic features: a distinct diagnostic entity or a more severe subtype of depression?

Acta Psychiatrica Scandinavica

Volumn 82, Issue 6, 1990, Pages 439-444

  Maj, M ^a   Pirozzi, R ^a   Di Caprio, E L ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

depression; mood congruence; psychosis

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; FEMALE; HUMAN; MALE; PSYCHOSIS;

ADULT; AFFECTIVE DISORDERS, PSYCHOTIC; CROSS-SECTIONAL STUDIES; DELUSIONS; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HALLUCINATIONS; HUMAN; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS;

EID: 0025633314     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1990.tb03075.x     Document Type: Article

References (51)

1. The significance of psychotic affective disorders
2. Delusional unipolar depression. Description and drug response
3. Psychotic features in major depression
4. Psychotic depressive disorder
5. Family history in delusional depression
6. Phenomenology and family history in DSM‐III psychotic depression
7. Delusional depression. A distinct illness
8. Is delusional depression related to bipolar disorder
9. Subtypes of depression: family study perspective
10. Delusional and nondelusional unipolar depression: evidence for distinct subtypes
11. Psychotic depression: a separate entity
12. Delusional depression. A distinct clinical entity
13. Primary unipolar depression and the prognostic importance of delusions
14. Outcome in schizoaffective, psychotic, and nonpsychotic depression
15. Depression, drugs, and delusions
16. Stability of psychotic symptomatology (delusions, hallucinations), affective syndromes, and schizophrenic symptoms (thought disorder, incongruent affect) over episodes in remitting psychoses
17. Delusional depression: phenomenology and response to treatment. A prospective study
18. Delusional and non‐delusional depression in late life. Evidence for distinct subtypes
19. Electroencephalographic sleep in psychotic depression
20. Depressions, delusions and suicide
21. Recurrent psychotic depression. Evidence of diagnostic stability
22. Type and content of delusions in unipolar psychotic depression
23. Definitions of depression: concordance and prediction of outcome
24. Depression, delusions, and drug response
25. Imipramine response in deluded depressive patients
26. Factors associated with response to lithium prophylaxis in DSM‐III major depression and bipolar disorder
27. Major depression with mood‐congruent or mood‐incongruent psychotic features: outcome after 40 years
28. Neuroendocrine dysfunction in genetic subtypes of primary unipolar depression
29. The dexamethasone suppression test in affective disorder: relationship to clinical and genetic subgroups
30. Dexamethasone suppression test in primary depression: significance of family history and psychosis
31. Response to dexamethasone in psychotic depression
32. Dexamethasone suppression test in the clinical setting
33. The dexamethasone suppression test: identification of subtypes of depression
34. The specificity of the dexamethasone suppression test in endogenous depressive patients
35. Delusional versus non‐delusional depression: neurochemical differences
36. Higher CSF levels of HVA and 5‐HIAA in delusional compared to nondelusional depression
37. Serum dopamine‐beta‐hydroxylase activity in the affective psychoses and schizophrenia
38. Biochemical and neuroendocrine studies in psychotic and nonpsychotic depressions
39. Psychotic forms of depression and mania
40. Comprehensive Psychopathological Rating Scale: CPRS
41. Response to dexamethasone suppression test in schizoaffective disorder, depressed type
42. The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance
43. The prediction of outcome in schizophrenia. I. Characteristics of outcome
44. WHO collaborative study on impairments and disabilities associated with schizophrenic disorders
45. The treatment of psychotic major depressive disorder with drugs and electroconvulsive therapy